ARTICLE | Finance
BiomX’s balance
How BiomX attracted Seventure, other microbiome investors to A round
May 19, 2017 8:43 PM UTC
After identifying a handful of novel bacterial targets and bacteriophage candidates, BiomX Ltd. was able to attract $24 million in series A funding from some of industry's most active microbiome players.
OrbiMed Advisors, the Johnson & Johnson Innovation - JJDC Inc. unit of Johnson & Johnson (NYSE:JNJ) and Takeda Ventures co-led the round, which closed on May 15. Seventure Partners, Mirae Asset, SBI Japan-Israel Innovation Fund and undisclosed European investors participated. ...
BCIQ Company Profiles